CMAX vs. IDEX, ICLK, SAI, FRSX, STBX, MTEK, AHI, MLGO, OMH, and TOMZ
Should you be buying CareMax stock or one of its competitors? The main competitors of CareMax include Ideanomics (IDEX), iClick Interactive Asia Group (ICLK), SAI.TECH Global (SAI), Foresight Autonomous (FRSX), Starbox Group (STBX), Maris-Tech (MTEK), Advanced Health Intelligence (AHI), MicroAlgo (MLGO), Ohmyhome (OMH), and TOMI Environmental Solutions (TOMZ). These companies are all part of the "business services" sector.
Ideanomics (NASDAQ:IDEX) and CareMax (NASDAQ:CMAX) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, community ranking, dividends, media sentiment, valuation, analyst recommendations and profitability.
Ideanomics has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500. Comparatively, CareMax has a beta of 0.87, indicating that its share price is 13% less volatile than the S&P 500.
CareMax has a consensus price target of $45.00, indicating a potential upside of 1,284.62%. Given Ideanomics' higher possible upside, analysts plainly believe CareMax is more favorable than Ideanomics.
4.4% of Ideanomics shares are owned by institutional investors. Comparatively, 65.9% of CareMax shares are owned by institutional investors. 0.6% of Ideanomics shares are owned by company insiders. Comparatively, 26.9% of CareMax shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
In the previous week, Ideanomics had 1 more articles in the media than CareMax. MarketBeat recorded 1 mentions for Ideanomics and 0 mentions for CareMax. CareMax's average media sentiment score of 0.00 equaled Ideanomics'average media sentiment score.
CareMax has a net margin of -90.98% compared to CareMax's net margin of -931.66%. Ideanomics' return on equity of -35.76% beat CareMax's return on equity.
Ideanomics received 66 more outperform votes than CareMax when rated by MarketBeat users. Likewise, 68.81% of users gave Ideanomics an outperform vote while only 30.00% of users gave CareMax an outperform vote.
Ideanomics has higher earnings, but lower revenue than CareMax. CareMax is trading at a lower price-to-earnings ratio than Ideanomics, indicating that it is currently the more affordable of the two stocks.
Summary
CareMax beats Ideanomics on 8 of the 15 factors compared between the two stocks.
Get CareMax News Delivered to You Automatically
Sign up to receive the latest news and ratings for CMAX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CMAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
